Collagen Solutions PLC Attending UK Investor Show

TIDMCOS

Collagen Solutions PLC

23 March 2017

Collagen Solutions Plc

(the "Company" or the "Group")

UK Investor Show 2017 attendance

Collagen Solutions plc (AIM: COS), the developer and manufacturer of medical grade collagen components for use in regenerative medicine, medical devices and in-vitro diagnostics will be participating in the UK Investor Show which will be taking place on 1 April 2017 at the Queen Elizabeth II Conference Centre in Westminster, London SW1P 3EE. The Senior Management will be available from 8:30am until 5:30pm to discuss recent positive events for the Company as well as their strategy for accelerating growth. The Collagen team at the show will be led by David Evans, the Chairman of Collagen Solutions, who will be presenting to the investor audience "A Chairman's Story", his view of where the Company has come from, what it has achieved to-date and why it has such a pivotal position in the rapidly growing regenerative medicine market. You will find Collagen Solutions at Booth 65 where the management will be available to discuss the opportunities the Company has and answer any questions you may have.

About Collagen Solutions:

Collagen Solutions Plc is a global supplier, developer, and manufacturer of medical grade collagen, tissues, and related medical devices and components for use in regenerative medicine, medical devices and in-vitro diagnostics and research. The Company is also expanding its range of biomaterials-based finished medical devices based on its internal and acquired intellectual property for commercialisation with partners via licensing and distribution arrangements, including ChondroMimetic, an osteochondral scaffold for repairing cartilage defects in the knee. The Company's products are used in a wide variety of applications including orthopaedics, cardiovascular, dental, plastic surgery, wound healing, neurology and urology.

For additional information, please visit www.collagensolutions.com.

Enquiries:

 
  Collagen Solutions Plc                                            Contact via Walbrook 
 Jamal Rushdy, Chief Executive 
  Officer 
 Gill Black, Chief Financial 
  Officer 
 
 Cenkos Securities plc (Nominated                                     Tel: 0207 397 8900 
  Adviser and Broker) 
  Stephen Keys 
  Steve Cox 
 
 Walbrook PR                           Tel: 020 7933 8780 or collagen@walbrookpr.com 
 Mike Wort                                                            Mob: 07900 608 002 
 Anna Dunphy                                                          Mob: 07876 741 001

This information is provided by RNS

The company news service from the London Stock Exchange

END

NRAOKBDBPBKDBNB

(END) Dow Jones Newswires

March 23, 2017 03:01 ET (07:01 GMT)

Grafico Azioni Healthcare Inv (LSE:HIO)
Storico
Da Dic 2024 a Gen 2025